New research on parasitic worm

  • April 23, 2014
New research on parasitic worm

New research which moves scientists one step closer to finding a vaccine for a parasitic worm that infects more than 200 million people worldwide has been published.

New research which moves scientists one step closer to finding a vaccine for a parasitic worm that infects more than 200 million people worldwide has been published.

The research, led by Gates Cambridge Alumnus Sukrit Silas, is in the International Journal for Parasitology.

Infection by the parasitic worm Schistosoma mansoni occurs in 54 countries around the world and is a serious health problem in sub-Saharan Africa. Symptoms can include fever, a rash, aching, a cough, diarrheoa and gland enlargement. For those living where the parasite is endemic, repeated exposure can lead to life-long infection, although partial immunity does eventually develop. Infection by the worm is second only to malaria in its global impact on human populations. Over the past two decades, it has been argued that a particular kind of antibody response in chronic patients of schistosomiasis – known as Immunoglobulin E (IgE) – might serve to protect people from reinfection by the parasite.

It has also become clear that IgE-mediated immune responses play a central role in allergies, leading some scientists to propose that allergies might simply be misguided anti-parasite responses. This means for example, that people with allergies to shellfish might develop rashes and inflammation upon exposure to shrimp because their immune system “thinks” it is under parasitic attack and mounts an aggressive defence.

Sukrit [2011], whose work is based on his MPhil in Pathology, which was supported by a Gates Cambridge Scholarship, says: “In this research, we turned this idea on its head, and argued that in order to find “signatures” of the parasite that might be easy for the human immune system to recognise, our best bet would be to look for worm proteins that “look like” already known allergens. Such protein signatures could then be purified and used to immunise people who live in endemic regions against schistosomiasis. We first purified and characterised several different variants of S. mansoni tropomyosin – a predominantly muscle-related protein that is present in all animals and is the major food allergen in shellfish. We then tested whether blood serum from chronically infected patients in Musoli – a fishing village in Uganda – contained antibodies against these purified tropomyosins, and whether these immune responses were correlated with resistance to reinfection. Indeed, we found that IgE responses to one tropomyosin variant in S. mansoni were significantly correlated with immunity.”

Sukrit is currently at Stanford University where he is doing a PhD in Chemical and Systems Biology.

*Picture credit: Wiki Commons and US Army Africa. It depicts the Medical Civic Action Programme in Shinile Woreda, Ethiopia, 2010.

Latest News

Affecting change for the Māori community

Self-determination lies at the centre of Māori culture. “It’s a way of life,” says Chris Tooley. That idea is also at the heart of his PhD studies at Cambridge and his subsequent work in Parliament and in the community. Chris grew up with a strong sense of being part of the Māori community. He has ancestral […]

On the COVID frontline

Three Gates Cambridge scholars who have been on the medical frontline during the COVID-19 pandemic will be speaking about their experiences at a virtual event next weekend. The event, organised by the Gates Cambridge Alumni Association, will be moderated by Elizabeth Dzeng, Assistant Professor of Medicine at the University of California, San Francisco in the […]

New game tackles Covid conspiracies

A new online game that puts players in the shoes of a purveyor of fake pandemic news is the latest tactic in the UK Government’s efforts to tackle the deluge of coronavirus misinformation that is misleading many and costing lives across the world. Launched to the public today, the Go Viral! game has been developed by the […]

“Democracy does not work on a ‘trust me’ basis”

When Jennifer Gibson started her MPhil at Cambridge in 2001 as part of the inaugural class of Gates Scholars, no-one knew what it meant to be a Gates Cambridge Scholar. Twenty years later, Jennifer is now a human rights lawyer focused on national security issues, something she never could have anticipated, but which she credits in no small part […]